N/A
Completed N=20
Development and Validation of a Tumour Oxygenation Monitoring Probe
Source: ClinicalTrials.gov NCT03982355 ↗Enrolled (actual)
20
Serious AEs
—
Results posted
Sep 2024
Primary outcomePrimary: Count of MRIs Successfully Modelled for Oxygen Correlation — 10; 10 MRIs analyses
Summary
Laboratory based study in which novel tissue oxygenation probe with the potential provide novel means for assessing response to cancer treatment will be developed and validated.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Count of MRIs Successfully Modelled for Oxygen Correlation |
10; 10 | — |
Eligibility Criteria
Inclusion Criteria
- MRIs from Breast or Rectal Cancer patients (10 of each)
- Locally advanced Cancers (Stage 2 or 3)
- Patients who went on to receive neoadjuvant chemoradiotherapy.
- Anonymised scans
Exclusion Criteria
- MRIs from patients under the age of 18, or older than 99 years old will be excluded.
- MRIs from patients who did not receive neoadjuvant therapy for cancer will be excluded.
Data sourced from ClinicalTrials.gov (NCT03982355). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.